Search
Menu
contact us
Home
About Us
Company
Contact
Leadership
Facilities
Careers
Tandem Mass Tags (TMT)
Trademarks & Copyrights
Services
Services
About our Services
Discovery Based Proteomics
Advantages
Label Free Versus Tandem Mass Tags
TMT based LC-MS2 and LC-MS3
Post Translational Modifications
TMTcalibrator
Super Depletion
Mass Spectrometry in the AI/ML area
Protein Degrader/PROTAC assays
Single Cell Proteomics
Speciality Proteomics
Overview
IP Pull Down Sample Pre-Treatment
Off-Gel protein sequencing
Peptidomics and MHC I/II Immunopeptidomics
Protein Degrader/PROTAC Assays
Computational Proteomics Driven by Machine Learning and Artificial Intelligence
Targeted Assays
Targeted Assays
Overview
Developing a targeted assay
Tryptophan and its Metabolites
Quality Management
Summary
ISO9001:2015 Certification
GCLP Compliance
Bioinformatics
Working with us
Working with us
Summary of our Proteomic Servies
Types and Quantities of Samples Required for Analysis
How to discuss and order a project with us
Sample analysis and reporting
News & Events
News
Events
Resources
Resources
Case Studies
Publications
Posters
FAQs
Investors
Search
contact us
contact us
Final results for the year ended 31 December 2022
April 04, 2023
The Company is pleased to announce its audited results for the year ended 31 December 2022.
View PDF version
Back to News